Peripheral Vasodilator Drugs Global Market Report 2025

Description

Peripheral vasodilator drugs are medications that primarily act on blood vessels outside of the heart and brain, specifically targeting the peripheral circulation. These drugs are used to widen (dilate) blood vessels, thereby reducing resistance to blood flow and lowering blood pressure.

The main types of peripheral vasodilator drugs include calcium channel blockers, direct-acting vasodilators, alpha-adrenergic blockers, potassium channel activators, nitrates, and others. Calcium channel blockers are medications that relax and widen blood vessels by preventing calcium from entering the cells of the heart and arterial walls, which helps reduce blood pressure and improve blood flow. These drugs are indicated for conditions such as hypertension, angina, heart failure, and others, and are used in settings such as hospitals and retail pharmacies.

The peripheral vasodilator drugs market research report is one of a series of new reports from the business research company that provides peripheral vasodilator drugs market statistics, including peripheral vasodilator drugs industry global market size, regional shares, competitors with an peripheral vasodilator drugs market share, detailed peripheral vasodilator drugs market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vasodilator drugs industry. This peripheral vasodilator drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral vasodilator drugs market size has grown strongly in recent years. It will grow from $6.27 billion in 2024 to $6.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and growing patient preference for non-surgical or minimally invasive treatment options.

The peripheral vasodilator drugs market size is expected to see strong growth in the next few years. It will grow to $8.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increased collaboration, real-world evidence, gene therapy, preventive interventions, and value-based healthcare.

The growing prevalence of cardiovascular diseases (CVDs) is expected to drive the expansion of the peripheral vasodilator drug market in the coming years. CVDs encompass a range of disorders affecting the heart and blood vessels, often caused by atherosclerosis, which can lead to conditions such as heart attacks, strokes, hypertension, and heart failure. These diseases primarily result from sedentary lifestyles, poor diets, aging populations, rising obesity rates, and related health issues like diabetes and hypertension. Peripheral vasodilators play a key role in managing cardiovascular diseases by improving blood flow, reducing blood pressure, easing the heart's workload, and alleviating symptoms of conditions like peripheral arterial disease. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that doctor-certified deaths from coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. As such, the increasing prevalence of CVDs is contributing to the growth of the peripheral vasodilator drug market.

Major companies in the peripheral vasodilator drugs market are focusing on developing triple-drug combination therapies to optimize treatment outcomes and expand their market share in cardiovascular therapeutics. Triple-drug combination therapy is an antihypertensive fixed-dose combination (FDC) targeting patients who have not achieved adequate blood pressure control with dual-drug therapies or cannot tolerate diuretic-based combinations. For instance, in August 2023, Ajanta Pharma Limited, an India-based pharmaceutical company specializing in cardiology, introduced Met XL AMT, a novel triple-drug combination to manage hypertension among Indian patients. This FDC includes three antihypertensive agents, Telmisartan, Amlodipine, and Metoprolol. These agents work together to lower blood pressure by relaxing blood vessels, characteristic of peripheral vasodilators. The drug is specifically approved by DCGI for managing uncontrolled hypertension alongside stable coronary artery disease, making it the world's first FDC of metoprolol succinate (extended-release) 50 mg, amlodipine 5 mg, and telmisartan 40 mg.

In March 2022, Advent International Corporation, a US-based private equity investor, acquired the Mexico and Brazil pharmaceutical businesses from Perrigo Company plc for an undisclosed amount. This acquisition enhances Advent's regional investment strategy within the pharmaceutical sector, leveraging over two decades of industry experience to strengthen its market position. Perrigo Company plc is an Ireland-based pharmaceutical and health and wellness drug manufacturer that produces vasodilators such as nitroglycerin for hypertension.

Major companies operating in the peripheral vasodilator drugs market are Pfizer Inc., Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Takeda Pharmaceutical Company, Gilead Sciences Inc, Amgen Inc, Boehringer Ingelheim International GmbH, Merck & Co, Viatris Inc., Baxter, Teva Pharmaceutical Industries, Astellas Pharma, Daiichi Sankyo Company, Limited, Sun Pharmaceutical Industries, Mitsubishi Tanabe Pharma, Cipla Limited, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Ipca Laboratories, Alembic Pharmaceuticals

North America was the largest region in the peripheral vasodilator drugs market in 2024. The regions covered in the peripheral vasodilator drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the peripheral vasodilator drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral vasodilator drugs market consists of sales of angiotensin II receptor blockers (ARBs), nitric oxide donors, direct renin inhibitors, and endothelin receptor antagonists. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral Vasodilator Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral vasodilator drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral vasodilator drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peripheral vasodilator drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Calcium Channel Blockers; Direct-Acting Vasodilators; Alpha-Adrenergic Blockers; Potassium Channel Activators; Nitrates; Other Types
2) By Indication: Hypertension; Angina; Heart Failure; Other Indications
3) By Application: Hospital; Retail Pharmacies; Other Applications
Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines; Non-Dihydropyridines
2) By Direct-Acting Vasodilators: Hydralazine; Minoxidil; Nitroprusside
3) By Alpha-Adrenergic Blockers: Prazosin; Doxazosin; Terazosin
4) By Potassium Channel Activators: Nicorandil; Diazoxide
5) By Nitrates: Nitroglycerin; Isosorbide Dinitrate; Isosorbide Mononitrate
6) By Other Types: Phosphodiesterase Inhibitors; Endothelin Receptor Antagonists
Companies Mentioned: Pfizer Inc.; Bayer AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30926

1. Executive Summary

2. Peripheral Vasodilator Drugs Market Characteristics

3. Peripheral Vasodilator Drugs Market Trends And Strategies

4. Peripheral Vasodilator Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Peripheral Vasodilator Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Peripheral Vasodilator Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Peripheral Vasodilator Drugs Market Growth Rate Analysis
5.4. Global Peripheral Vasodilator Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Peripheral Vasodilator Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Peripheral Vasodilator Drugs Total Addressable Market (TAM)

6. Peripheral Vasodilator Drugs Market Segmentation

6.1. Global Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcium Channel Blockers
Direct-Acting Vasodilators
Alpha-Adrenergic Blockers
Potassium Channel Activators
Nitrates
Other Types
6.2. Global Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Angina
Heart Failure
Other Indications
6.3. Global Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Retail Pharmacies
Other Applications
6.4. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dihydropyridines
Non-Dihydropyridines
6.5. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Direct-Acting Vasodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydralazine
Minoxidil
Nitroprusside
6.6. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Alpha-Adrenergic Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prazosin
Doxazosin
Terazosin
6.7. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Potassium Channel Activators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nicorandil
Diazoxide
6.8. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitroglycerin
Isosorbide Dinitrate
Isosorbide Mononitrate
6.9. Global Peripheral Vasodilator Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phosphodiesterase Inhibitors
Endothelin Receptor Antagonists

7. Peripheral Vasodilator Drugs Market Regional And Country Analysis

7.1. Global Peripheral Vasodilator Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Peripheral Vasodilator Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peripheral Vasodilator Drugs Market

8.1. Asia-Pacific Peripheral Vasodilator Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peripheral Vasodilator Drugs Market

9.1. China Peripheral Vasodilator Drugs Market Overview
9.2. China Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peripheral Vasodilator Drugs Market

10.1. India Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peripheral Vasodilator Drugs Market

11.1. Japan Peripheral Vasodilator Drugs Market Overview
11.2. Japan Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peripheral Vasodilator Drugs Market

12.1. Australia Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peripheral Vasodilator Drugs Market

13.1. Indonesia Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peripheral Vasodilator Drugs Market

14.1. South Korea Peripheral Vasodilator Drugs Market Overview
14.2. South Korea Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peripheral Vasodilator Drugs Market

15.1. Western Europe Peripheral Vasodilator Drugs Market Overview
15.2. Western Europe Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peripheral Vasodilator Drugs Market

16.1. UK Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peripheral Vasodilator Drugs Market

17.1. Germany Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peripheral Vasodilator Drugs Market

18.1. France Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peripheral Vasodilator Drugs Market

19.1. Italy Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peripheral Vasodilator Drugs Market

20.1. Spain Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peripheral Vasodilator Drugs Market

21.1. Eastern Europe Peripheral Vasodilator Drugs Market Overview
21.2. Eastern Europe Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peripheral Vasodilator Drugs Market

22.1. Russia Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peripheral Vasodilator Drugs Market

23.1. North America Peripheral Vasodilator Drugs Market Overview
23.2. North America Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peripheral Vasodilator Drugs Market

24.1. USA Peripheral Vasodilator Drugs Market Overview
24.2. USA Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peripheral Vasodilator Drugs Market

25.1. Canada Peripheral Vasodilator Drugs Market Overview
25.2. Canada Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peripheral Vasodilator Drugs Market

26.1. South America Peripheral Vasodilator Drugs Market Overview
26.2. South America Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peripheral Vasodilator Drugs Market

27.1. Brazil Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peripheral Vasodilator Drugs Market

28.1. Middle East Peripheral Vasodilator Drugs Market Overview
28.2. Middle East Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peripheral Vasodilator Drugs Market

29.1. Africa Peripheral Vasodilator Drugs Market Overview
29.2. Africa Peripheral Vasodilator Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Peripheral Vasodilator Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Peripheral Vasodilator Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peripheral Vasodilator Drugs Market Competitive Landscape And Company Profiles

30.1. Peripheral Vasodilator Drugs Market Competitive Landscape
30.2. Peripheral Vasodilator Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

31. Peripheral Vasodilator Drugs Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Novartis AG
31.3. GSK plc
31.4. Takeda Pharmaceutical Company
31.5. Gilead Sciences Inc
31.6. Amgen Inc
31.7. Boehringer Ingelheim International GmbH
31.8. Merck & Co
31.9. Viatris Inc.
31.10. Baxter
31.11. Teva Pharmaceutical Industries
31.12. Astellas Pharma
31.13. Daiichi Sankyo Company, Limited
31.14. Sun Pharmaceutical Industries
31.15. Mitsubishi Tanabe Pharma

32. Global Peripheral Vasodilator Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peripheral Vasodilator Drugs Market

34. Recent Developments In The Peripheral Vasodilator Drugs Market

35. Peripheral Vasodilator Drugs Market High Potential Countries, Segments and Strategies

35.1 Peripheral Vasodilator Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Peripheral Vasodilator Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Peripheral Vasodilator Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer